PHONE:  03 9700 7666

Dr Champa Nataraja

MBBS, FRACP PhD

Dr Champa Nataraja is a consultant rheumatologist at Arthritis and Rheumatology centre, and
Articulated Health and a physician-scientist.
Dr Nataraja graduated (MBBS) from Rajiv Gandhi University of Health Sciences, INDIA.
She undertook basic physician training at the University Hospital Geelong, Victoria in 2015.
She completed specialist training in Rheumatology at Monash Health and the Royal Hobart
Hospital. She is a fellow of The Royal Australasian College of Rheumatology and a member
of the Australian Rheumatology Association.
Dr Nataraja completed her PhD (Doctor of Philosophy) in 2020 from Monash University.
She has presented her research at the national and international conferences in
Rheumatology.
Dr Nataraja has a special interest in inflammatory arthritis, musculoskeletal diseases,
connective tissue diseases, osteoarthritis as well as complex rheumatic diseases. She aims to
provide a high-quality medical service in rheumatology and care for her patients.
Outside of work, Dr Nataraja enjoys playing badminton and swimming.

Publications.
1) Nataraja, C., Morand, E., & Mak, A. (2025). 54 - Systemic glucocorticoid therapy for SLE. In
D. J. Wallace, B. H. Hahn, A. Askanase, M. K. Crow, D. A. Isenberg, A. L. Cava, M. A.
McMahon, B. P. Tsao, S. Venuturupalli, & M. H. Weisman (Eds.), Dubois' Lupus
Erythematosus and Related Syndromes (Tenth Edition) (pp. 750-762). New Delhi: Elsevier.
2) Nataraja C, Flynn J, Dankers W, Northcott M, Zhu W, Sherlock R, Bennett TJ, Russ BE,
Miceli I, Pervin M, D'Cruz A, Harris J, Morand EF, Jones SA. GILZ regulates type I
interferon release and sequesters STAT1. J Autoimmun. 2022 Jul;131:102858. doi:
10.1016/j.jaut.2022.102858. Epub 2022 Jul 8. PMID: 35810690.

3) Nataraja, C., Zhu, W., Dankers, W., Jones, S.A. (2021). Balancing Strategies: GC and GILZ
Axis. In: Hoi, A. (eds) Pathogenesis of Systemic Lupus Erythematosus. Springer, Cham.
https://doi.org/10.1007/978-3-030-85161-3_10
4) Nataraja, C., Dankers, W., Flynn, J., Lee, J., Zhu, W., Vincent, F. B., Gearing, L. J., Ooi, J.,
Pervin, M., Cristofaro, M. A., Sherlock, R., Hasnat, M. A., Harris, J., Morand, E. F., & Jones,
S. A. (2021). GILZ Regulates the Expression of Pro-Inflammatory Cytokines and Protects
Against End-Organ Damage in a Model of Lupus. Frontiers in immunology, 12, 652800.
https://doi.org/10.3389/fimmu.2021.652800
5) Melissa Northcott., Linden J Gearing., Hieu T Nim., Champa Nataraja., Prof Paul Hertzog.,
Dr Sarah Jones., & Prof Eric Morand (2021). Glucocorticoid gene signatures in systemic
lupus erythematosus and the effects of type I interferon: a cross-sectional and in-vitro study.
The Lancet Rheumatology, Volume 3, Issue 5, 2021
6) Al-Heilfi A, Nataraja C, Cooley H, Batt T. Large-vessel vasculitis in graft-versus-host
disease: a case report. J Med Case Rep. 2021 Sep 28;15(1):478. doi: 10.1186/s13256-021-
03067-y. PMID: 34579779; PMCID: PMC8477472.
7) Haiyin Liu, Kayla R. Wilson, Patrick Schriek, Christophe Macri, Annabelle B. Blum, Lauren
Francis, Melanie Heinlein, Champa Nataraja, James Harris, Sarah A. Jones, Daniel H.

D. Gray, Jose A. Villadangos, Justine D. Mintern (2020). Ubiquitination of MHC Class II Is
Required for Development of Regulatory but Not Conventional CD4  +  T Cells. The Journal of
Immunology September 1, 2020, 205 (5) 1207 1216; DOI: 10.4049/jimmunol.1901328
8) Nataraja, C., & Morand, E. (2018). Book Chapter 53, SYSTEMIC GLUCOCORTICOID
THERAPY FOR SLE. Dubois' Lupus Erythematosus and Related Syndromes, 9e, Elsevier,
2018
9) Champa Nataraja and Hedley Griffiths, “Atypical Cutaneous Manifestations in Adult-Onset
Still’s Disease,” Case Reports in Rheumatology, vol. 2016, Article